Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.19 USD | +7.47% | 0.00% | -41.26% |
04-01 | Sector Update: Health Care Stocks Slide Late Afternoon | MT |
04-01 | Pulse Biosciences Shares Fall After Q4 Results, Rights Issue Plans | MT |
Business Summary
Number of employees: 61
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Danahy
CEO | Chief Executive Officer | 54 | 22-02-13 |
Chief Tech/Sci/R&D Officer | - | 23-05-02 | |
Chief Tech/Sci/R&D Officer | - | - | |
Edison Manuel
COO | Chief Operating Officer | - | 17-03-31 |
David Danitz
CTO | Chief Tech/Sci/R&D Officer | - | 15-10-31 |
Darrin Uecker
CTO | Chief Tech/Sci/R&D Officer | 59 | 15-09-14 |
Corporate Officer/Principal | 63 | 19-03-17 | |
William Knape
LAW | General Counsel | - | 18-05-10 |
Patty Perla
HRO | Human Resources Officer | - | 20-02-29 |
Joseph Talarico
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CHM | Chairman | 79 | 17-11-01 |
Director/Board Member | 46 | 17-11-01 | |
Darrin Uecker
CTO | Chief Tech/Sci/R&D Officer | 59 | 15-09-14 |
Mahkam Zanganeh
BRD | Director/Board Member | 52 | 17-02-09 |
Director/Board Member | 63 | 14-12-31 | |
Shelley Spray
BRD | Director/Board Member | 59 | 21-11-23 |
Director/Board Member | 57 | 20-08-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,225,333 | 16,356,958 ( 29.62 %) | 0 | 29.62 % |
Company contact information
Pulse Biosciences, Inc.
3957 Point Eden Way
94545, Hayward
+510 906 4600
http://www.pulsebiosciences.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-41.26% | 397M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- PLSE Stock
- Company Pulse Biosciences, Inc.